89Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer - Bensch, Frederike; Elly L van der Veen; Marjolijn N Lub-de Hooge; Jorritsma-Smit, Annelies; Boellaard, Ronald; Kok, Iris C; Oosting, Sjoukje F; Schröder, Carolina P; T Jeroen N Hiltermann; Anthonie J van der Wekken; Groen, Harry J M; Kwee, Thomas C; et al. (Nature medicine, 2018)
Keywords: Antibodies; Apoptosis; Biomarkers; Biopsy; Cancer; Cell death; Emission analysis; Feasibility studies; Gene sequencing; Immunohistochemistry; Immunotherapy; Lesions; Lymphoid tissue; Medical imaging; Monoclonal antibodies; Patients; PD-1 protein; PD-L1 protein; Positron emission; Positron emission tomography; Predictions; Proteins; Ribonucleic acid; RNA; Targeted cancer therapy; Tomography; Tumors; Zirconium; Zirconium isotopes